Salvia BioElectronics raises €53M to revolutionize migraine treatment with neuromodulation therapy
Eindhoven-based health tech startup Salvia BioElectronics has raised €53 million in a Series B round to accelerate the clinical and commercial rollout of its migraine treatment technology.

The best Articles in our Network